A new position for Michelle Burke with the industry nominated PBAC member and AusBiotech board member appointed to Cancer Australia's Australian Brain Cancer Mission Strategic Advisory Group.
Ms Burke, who was appointed to the PBAC last year following a long career as a senior market access executive with Bristol-Myers Squibb, is one of several appointments to the group tasked with providing Cancer Australia with strategic advice and guidance on achieving the goal of doubling survival rates and improving the quality of life of patients with brain cancer over the next 10 years.
Professor Adele Green AC of QIMR Berghofer has been appointed chair of a group that also includes patients and consumers, clinicians, researchers, co-investors and a member of the Medical Research Future Fund’s (MRFF) Australian Medical Research Advisory Board.
Other members include Professor Doug Hilton AO and Professor Grant McArthur.
Health minister Greg Hunt announced the $100 million Australian Brain Cancer Mission in October last year. The mission is designed as a partnership between government, philanthropists, researchers and clinicians, patients and their families.
Government is contributing $50 million from the MRFF, Minderoo Foundation's Eliminating Cancer Initiative has committed $10 million, and the Cure Brain Cancer Foundation has committed $20 million. Further contributions are being sought by government.